CCRST - CU-0202P COPPER CHROMITE CATALYST
- MSDS: CCRST
- Manufacturer: ENGELHARD CORP
- Product Name: CU-0202P COPPER CHROMITE CATALYST
- National Stock Number: 6810-00N074493
Product Identification
Product ID:CU-0202P COPPER CHROMITE CATALYST
MSDS Date:01/12/1995
FSC:6810
NIIN:00N074493
MSDS Number: CCRST
Responsible Party
ELYRIA, OH 44035
US
Emergency Phone: 202-483-7616;800-424-9300(CHEMTREC)
Info Phone: 800-321-2747
Cage: ENGEL
Contractor
Telephone: 216-292-9200
Cage: ENGEL
Ingredients
COPPER OXIDE
CAS: 1317-38-0
RTECS: GL7900000
Fraction By Weight: 75%
OSHA PEL 1 MG CU/M3
ACGIH TLV: 1 MG CU/M3
COPPER CHROMITE
CAS: 12018-10-9
Fraction By Weight: 25%
OSHA PEL N/K
ACGIH TLV: N/K
ECOLOGICAL INFORMATION.
RTECS: 9999999ZZ
(SPCC). SUCH PLAN SHOULD INCL PROC APPLIC TO
RTECS: 9999999ZZ
DISP
RTECS: 9999999ZZ
ABOVE PROC SHOULD BE FOLLOWED. ADDITIONALLY, PROPER
RTECS: 9999999ZZ
EXPOS CONTROL/PERSONAL PROTECTION), &
RTECS: 9999999ZZ
STATE & LOCAL DISP LAWS & REGS WILL DETERM
RTECS: 9999999ZZ
REQUIREMENTS ARE DEPENDENT ON HAZ CLASSIFICATION &
RTECS: 9999999ZZ
CHEM
RTECS: 9999999ZZ
MAY MAKE WASTE MANAGEMENT INFO PRESENTED ABOVE
RTECS: 9999999ZZ
REGS MAY VARY; ALL WASTE MUST BE
RTECS: 9999999ZZ
Hazards
LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE:EYE:CAUSES MILD IRRIT.
SKIN:CAUSES IRRIT. ITCHING & ALLERGIC RXNS ARE POSS. INHAL:CAUSES
IRRIT, CHANGES IN NASAL MEMB, METALLIC TASTE IN MOUTH, RUNNY
NOSE/EYES & MAY CAUSE ALLERGIC RESP RXNS. PR LNGD/RPTD OVEREXP MAY
CAUSE LUNG DMG & COPPER POIS. INGEST:HARMFUL. MAY CAUSE ABDOM PAIN,
NAUS, VOMIT (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ:& DIARR. COPPER POIS CAN RSLT IN
HEMOLYTIC ANEMIA & KIDNEY, LIVER & SPLEEN DMG. SUSPECT CANCER
HAZ-RISK OF CANCER DEPENDS ON ROUTE, DURATION & LEV OF EXPOS.
PRLNGD/RPTD INHAL MAY CAUSE LUNG D MG. CAUSES EYE, SKIN & RESP RXN.
MAY CAUSE ALLERGIC SKIN & RESP RXN. PRLNGD/RPTD INHAL/INGEST MAY
CAUSE DMG TO (SUPDAT)
Medical Cond Aggravated by Exposure:MAY AGGRAVATE EXISTING RESP AND/OR
SKIN AILMENTS. INDIVIDUALS W/WILSON'S DISEASE ARE @ INCR RISK OF
COPPER POIS. NOTE:SEE SECTION 8 FOR EXPOS LIMS, SECTION 11 FOR TOX
INFO & SECTION 12 FOR (ING 4)
First Aid
First Aid:EYE & SKIN CONT:IMMED FLUSH EYES W/PLENTY OF WATER FOR @
LEAST 15 MINS. CALL PHYS. FLUSH SKIN W/WATER. INHAL:REMOVE TO FRESH
AIR. IF BRTHG IS DFCLT, OXYG SHOULD BE ADMINISTERED BY QUALIFIED
PERS. CALL PHYS. INGEST:IF PERSON IS CONSCIOUS & ABLE TO SWALLOW,
GIVE LG AMTS OF WATER TO DILUTE. IF VOMIT OCCURS, KEEP HEAD BELOW
HIPS TO HELP PVNT ASPIR. GET MED ATTN IMMED.
Fire Fighting
Extinguishing Media:USE WATER, CARBON DIOXIDE OR FOAM.
Fire Fighting Procedures:NONE EXPECTED. USE NIOSH APPROVED SCBA & FULL
PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:NOT A FIRE OR EXPLOSION HAZARD.
Accidental Release
Spill Release Procedures:CNTN SPILLAGE & SCOOP UP/VACUUM. NOTIFICATION
OF NATL RESPONSE CTR (800/424-8802) MAY BE REQD. REFER TO EPA, DOT
& APPLIC ST & LOC REGS FOR CURRENT RESPONSE INFO. IT IS REC EACH
USER ESTABLISH SPILL P REVENTION, CTL & COUNTERMEASURE PLAN (ING 5)
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
Handling
Handling and Storage Precautions:KEEP CONTAINER CLOSED. STORE IN COOL,
DRY LOCATION. AVOID GENERATING OR BREATHING DUST. AVOID CONTACT
WITH EYES, SKIN AND CLOTHING.
Other Precautions:USE ONLY WITH ADEQUATE VENTILATION. FOR COPPER &
CHROMIUM:REFER TO NIOSH MANUAL OF ANALYTICAL METHODS (NMAM), 4TH
EDITION, METHOD 7300.
Exposure Controls
Respiratory Protection:ANIOSH APPROVED RESPIRATOR AS NECESSARY.
Ventilation:GENERAL; LOCAL EXHAUST VENT AS NEC TO CONTROL ANY AIR
CONTAMINANTS TO W/IN THEIR PELS/TLVS DURING USE OF THIS PRODUCT.
Protective Gloves:RUBBER OR NEOPRENE GLOVES.
Eye Protection:ANSI APPRVD CHEM WORKERS GOGGLES .
Other Protective Equipment:ANSI APPRVD EYE WASH & DELUGE SHOWER .
Work Hygienic Practices:WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
EFTS OF OVEREXP:LUNGS, BLOOD, KIDNEYS, LIVER & NERV SYS. CARCIN:CERTAIN
CHROMIUM +6 CMPDS HAVE BEEN LISTED AS SUSPECT HUMAN CARCINS BY BOTH
NTP & IARC-GROUP 1, & AS CONFIRMED HUMAN CARCINS (A1) BY ACG IH.
THERE IS SUFFICIENT EVID ON CARCIN OF CHROMIUM & CHROMIUM +3 CMPDS.
PROD CNTNS BOTH CHROMIUM +3 & CHROMIUM +6 CMPDS.
Chemical Properties
Spec Gravity:1.1 (H*2O=1)
Solubility in Water:0.4% AT 25C
Appearance and Odor:BLACK POWDER, ODORLESS.
Stability
Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZING OR REDUCING AGENTS. ACIDS MAY FORM SOLUBLE METAL
SALTS.
Stability Condition to Avoid:NONE EXPECTED.
Hazardous Decomposition Products:NONE EXPECTED.
Disposal
Waste Disposal Methods:US EPA WASTE NO:D007. PROD, IF DISPOSED OF BY
ITSELF, IS HAZ WASTE UNDER EPA HAZ WASTE REGS BECAUSE OF
EXTRACTABLE CHROMIUM. WASTE MIX CNTNG PROD SHOULD BE TESTED FOR TOX
CHARACT (TC) USING CURRENT TO X CHARACT LEACHING PROC (TCLP).
FEDERAL, (ING 9)
Other Information
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.